Sunny Pharmtech Inc. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was TWD 177.37 million compared to TWD 155.4 million a year ago. Net loss was TWD 52.13 million compared to TWD 106.39 million a year ago.

Basic loss per share from continuing operations was TWD 0.38 compared to TWD 0.77 a year ago. Diluted loss per share from continuing operations was TWD 0.38 compared to TWD 0.77 a year ago.